Loading clinical trials...
Loading clinical trials...
)A Study to Evaluate the Erythropoietic Response in HCV/HIV Co-Infected Patients Receiving Combination Ribavirin/Interferon Therapy
Conditions
Interventions
Pegylated Interferon and Ribavirin
Start Date
September 1, 2000
Completion Date
November 1, 2003
Last Updated
May 19, 2011
NCT01875588
NCT04929028
NCT07071623
NCT03087253
NCT05012111
NCT07199335
Lead Sponsor
Ortho Biotech Products, L.P.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions